PathoVax LLC is a Johns Hopkins start-up biotechnology company headquartered in Baltimore, Maryland. Founded in 2014, the company has been focused on different medical applications for its proprietary Papillomavirus Virus-like Particle (VLP) platform.

 

Management & Operations Team

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon

Dr Wang trained in Papillomavirus VLPs at Johns Hopkins University. Prior to founding PathoVax, Joshua explored opportunities in innovation and venture creation at Flagship Ventures (now Flagship Pioneering).

Joshua Wang Ph.D.
Co-Founder & CEO
  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon

Dr Lai has more than 20 years’ of CMC operational experience in bio-pharmaceutical  and healthcare start-ups.
​Wen Bin obtained her Ph.D. from the University of Cambridge and received her MBA from the Singapore Management University, where she graduated as valedictorian.

Wenbin Lai Ph.D., MBA
Chemistry, Manufacturing & Controls Advisor (Singapore)

Dr Robert (‘”Bob”) Becker, PhD MBA is an experienced executive with a proven history in fostering partnerships with product development, cGMP manufacturing, clinical development and regulatory affairs 

Robert "Bob" Becker Ph.D., MBA
Business Management
  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon

Mr Jay Nadkarni joins PathoVax with 20+ years of experience in all aspects of new product commercialization and licensing; and has to his credit many successful licensing deals brought to fruition. He has a commendable track record in Innovation Management, Licensing, Business Development, and Technology Transfers for Biopharmaceuticals, Biologics, and Rx / OTC Pharmaceuticals all over the world with emphasis on Tier-1&2 Emerging Markets

Jay Nadkarni, MBA
Partnerships
 
 

Business Advisory Board

Bob Silverman_edited.png
Robert Silverman
Chairman of Business Advisory Board
Eric_edited_edited.jpg
Eric Richman, MBA
Business Advisor
Roger_edited.jpg
Roger Pomerantz M.D., FACP
Business Advisor
Sol_edited_edited.jpg
Solomon Langermann, Ph.D
Business Advisor

Scientific, Clinical Advisory Board, and Collaborators

RRoden_edited.jpg
Richard Roden, Ph.D
Co-director of Viral Oncology, Johns Hopkins School of medicine

 
Reinhard_edited.jpg
Reinhard Kirnbauer, MD
Director of Viral Oncology,
Medical University Vienna
huh-warner-1043257173_edited.jpg
Warner Huh, M.D
Professor and Division Director of the Division of Gynecologic Oncology at the University of Alabama at Birmingham.
schiller-john_edited.jpg
John Schiller, Ph.D
NIH Distinguished Investigator (Collaborator)